The Magazine for Sleep Professionals
Friday, June 12, 2026
Aesyra SA has announced the successful completion of its clinical investigation evaluating the efficacy and safety of AesyBite™ Active, an intelligent oral appliance designed to treat and prevent sleep bruxism through biofeedback. The clinical investigation demonstrated that AesyBite™ Active achieved a statistically significant and clinically meaningful reduction in sleep bruxism activity, exceeding the […]
Fisher & Paykel Healthcare has announced the United States launch of its newest nasal PAP mask for treating obstructive sleep apnea, the F&P Nova Nasal mask. Building on the success of the F&P Nova Micro™ and F&P Solo™ masks, the new F&P Nova Nasal delivers advanced technology to enhance mask […]
Idorsia Ltd announces that its novel treatment for insomnia disorder QUVIVIQ (Daridorexant) has been awarded the inaugural Prix Galien Bridges Award in the category of “Best Biotechnology & Pharmaceutical Product”. The award recognizes groundbreaking medicines, including biologics, gene therapies, and traditional pharmaceutical compounds, that advance patient care through scientific innovation. […]
SleepRes, Inc. announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Kricket PAP device, powered by Kairos Positive Airway Pressure (KPAP)™ for the treatment of obstructive sleep apnea (OSA) in patients weighing more than 66 lbs. The SleepRes PAP system is intended for home, hospital/institutional, […]
EnsoData Raises $20M to Accelerate Commercialization of AI-powered Sleep Solutions EnsoData, an innovator in AI healthtech solutions, announced a $20 million Series B financing led by Questa Capital. This new capital will enable EnsoData to accelerate adoption of its AI-powered sleep medicine solutions, improving the sleep care pathway for, in […]
An estimated one in three adults worldwide experience symptoms of insomnia, yet only a fraction of those suffering have access to specialists trained in cognitive behavioral therapy for insomnia (CBTI)—the gold standard in treatment.1,2 This unmet need has created a major bottleneck in behavioral sleep medicine, where demand far exceeds […]
Noctrix Health, Inc., the developer of the Nidra® Tonic Motor Activation (TOMAC) therapy for Restless Legs Syndrome (RLS), announced a significant expansion of private financing to accelerate its U.S. commercial launch. The company also announced several key leadership appointments to strengthen its commercial and scientific teams. Financing Update Noctrix Health […]
Nox Medical has announced the U.S. launch of the Nox SAS™ solution: an advanced EEG technology that enables simplified, clinically rigorous PSG testing in any setting. Designed for use with the Nox A1® PSG recorder, the Nox SAS solution eliminates the complexity of traditional PSG setups while maintaining clinical-grade signal […]
Nonin Medical has announced the launch of the Nonin Health® platform. The purpose-built cloud-based data ecosystem and software platform is designed for durable and home medical equipment (DME/HME) providers, sleep dentists, and sleep labs. With more than 1.5 million Americans currently requiring supplemental oxygen and millions more managing sleep-related breathing disorders, health care […]
ProSomnus Sleep Technologies announced significant progress on strategic programs. The key feature is the successful FDA registration of the company’s HWO2 buccal mucosal wellness oximeter. The ProSomnus HWO2 Device enables patients to monitor their nightly health and wellness during sleep, specifically, blood oxygen saturation, pulse rate and overall use time, […]
